US Patent 12059452 Fusion proteins
Patent 12059452 was granted and assigned to Eli Lilly and Company on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+398 characters)
US Patent 12059452 Fusion proteins
Article
Patent abstract
The present invention relates to fusion proteins comprising an insulin receptor agonist fused to a human IgG Fc region through the use of a peptide linker, and the use of such fusion proteins in the treatment of diabetes. The fusion protein of the present invention has an extended time action profile and is useful for providing basal glucose control for an extended period of time.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew Ihor Korytko0
Craig Duane Dickinson0
David Bruce Baldwin0
Gregory Alan Lazar0
John Michael Beals0
Jonathan Wesley Day0
Date of Patent
August 13, 2024
0Patent Application Number
175779320
Date Filed
January 18, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12059452 Fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
